Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE

4.79 (USD) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -72.7-135.352-108.501-73.958-35.879-7.74
Depreciation & Amortization 8.1216.2223.7452.1320.5370.072
Deferred Income Tax 0000.01700
Stock Based Compensation 18.12616.66911.6645.20.3540
Change In Working Capital 91.39772.466-2.1346.2864.2551.771
Accounts Receivables 0.3321.897-0000
Inventory 000000
Accounts Payables 6.2525.758-0.744-0.7063.4352.86
Other Working Capital 84.81364.811-1.396.9920.82-1.089
Other Non Cash Items -2.948-3.8072.760.967.68-0.276
Operating Cash Flow 41.996-43.802-92.466-59.363-23.053-6.173
Investing Activities:
Investments In Property Plant And Equipment -3.988-19.041-12.911-9.732-3.389-1.385
Acquisitions Net 000.1090.07900
Purchases Of Investments -230.361-103.151-384.417000
Sales Maturities Of Investments 189.897210.931178000
Other Investing Activites 00.062-0.206000
Investing Cash Flow -44.45288.801-219.219-9.653-3.389-1.385
Financing Activities:
Debt Repayment 000000.75
Common Stock Issued 0.94427.49220.055237.7560.0614.25
Common Stock Repurchased -0.641000-0.440
Dividends Paid 000000
Other Financing Activities 98.58927.4920.411139.81260.514.25
Financing Cash Flow 98.89227.49220.466377.56260.0615
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 96.43672.491-291.219308.54633.6187.442
Cash At End Of Period 229.117132.68160.19351.40942.8639.245